Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast
Access Status
Open access
Authors
Butler-Henderson, Kerryn Ann
Date
2014Supervisor
Prof. Andy Lee
Dr Nat Lenzo
Prof. Roger Price
Type
Thesis
Award
PhD
Metadata
Show full item recordSchool
School of Public Health
Collection
Abstract
The use of a hand-held positron emission tomography (PET) probe during breast surgery can potentially reduce the rate of second operations, having a number of implications. The PET probe tested in ductal carcinoma in situ (DCIS) surgery demonstrated to be 96.5% accurate when compared to pathology. This research examines the current technology available, the epidemiology of DCIS in Western Australia, testing of the radiopharmaceutical used with the probe and the PET probe itself.
Related items
Showing items related by title, author, creator and subject.
-
Haslam, N.J.; Whiteford, N.E.; Weber, G.; Prügel-Bennett, A.; Essex, J.W.; Neylon, Cameron (2008)© 2008 Haslam et al. Background: Sequencing by hybridisation is an effective method for obtaining large amounts of DNA sequence information at low cost. The efficiency of SBH depends on the design of the probe library to ...
-
Prakash, Baranivignesh; Parmar, Harisinh; Shah, Milin ; Pareek, Vishnu; Anthony, L.; Utikar, Ranjeet (2019)© Tsinghua University Press 2019. For a detailed characterisation of multiphase flows, a local measurement technique that is capable of quantifying both continuous and dispersed phases has to be employed. In the present ...
-
Pettersen, Jade Kristin (2010)Several resorcinarene and calixarene based receptors were synthesised with the overarching aim of developing selective hydrocarbon sensors for application in the petroleum exploration industry.Thioacetyl resorcinarenes ...